Exact Sciences to Use MDxHealth Methylation Biomarker, PCR Tech in Cologuard Test
January 13, 2011
Exact Sciences to Use MDxHealth Methylation Biomarker, PCR Tech in Cologuard Test
Exact has been evaluating several MDxHealth methylation biomarkers, among other biomarkers, as well as its methylation-specific PCR technology, under a previous licensing agreement.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Exact Sciences Files Second Module of PMA Application with FDA
February 18, 2013 / GenomeWeb Daily News - Exact Sciences Submits First Module of PMA for Cologuard MDx Colorectal Cancer Screen to FDA
December 11, 2012 / GenomeWeb Daily News - Study Supports MDxHealth's MGMT Methylation Test as Strong Brain Cancer Prognostic
July 13, 2011 / Pharmacogenomics Reporter - Rx/Dx, Biomarker Licensing Deals Bolster MDxHealth's Shift to Cancer Diagnostics in 2010
February 23, 2011 / Pharmacogenomics Reporter - Exact Sciences Using MDxHealth's Technology in Colon Cancer Test
January 10, 2011 / GenomeWeb Daily News